Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 4, 1996, Pages 485-489

  Blennow, M ^a,c   Rosengren, L ^b   Jonsson, S ^a   Forssberg, H ^a   Katz Salamon, M ^a   Hagberg, H ^b   Hesser, U ^a   Lagercrantz, H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain development; Glial fibrillary acidic protein; Neurodevelopmental sequelae; Preterm infant

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MARKER;

ARTICLE; BRAIN DEVELOPMENT; BRAIN INJURY; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GESTATIONAL AGE; HUMAN; NEWBORN; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029924578     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14068.x     Document Type: Article

References (25)

1. Rueger D, Huston J, Dahl D, Bignami A. Formation of 100 ü filaments from purified glial fibrillary acidic protein in vitro. J Mol Biol 1979;135:53-68
2. Roessmann U, Gambetti P. Astrocytes in the developing human brain. An immunohistochemical study. Acta Neuropathol 1986;70:308-13
3. Gould SJ, Howard S. An immunohistochemical study of the germinal layer in the late gestation human fetal brain. Neuropathol Appl Neurobiol 1987;13:421-37
4. Rosengren LE, Wikkelsø C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods 1994;51:197-204
5. Rosengren LE, Ahlsen G, Belfrage M, Gillberg C, Haglid KG, Hamberger A. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J Neurosci Methods 1992;44:113-19
6. Hayakawa R, Ushio Y, Mori T, Arita N, Yoshimine T, Maeda Y, et al. Levels in stroke patients of an astrocyte-specific cerebroprotein. Stroke 1979;10:685-9
7. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991;22:1254-8
8. Ahlsen G, Rosengren L, Belfrage M, Palm A, Haglid K, Hamberger A, et al. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry 1993;33:734-43
9. Ehlers S, Kyllerman M, Rosengren L. Glial fibrillary acidic protein in the cerebrospinal fluid of children investigated for encephalopathy. Neuropediatrics 1994;25:134-9
10. Blennow M, Hagberg H, Rosengren L. Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr Res 1995;37:260-4
11. Anonymous. Biochemical assessment of birth asphyxia. Lancet 1988;548-9
12. Blennow M, Zeman J, Dahlin I, Lagercrantz H. Monoamine neurotransmitters and metabolites in the cerebrospinal fluid following perinatal asphyxia. Biol Neonate 1995;67:407-13
13. Hagberg H, Thornberg E, Blennow M, Kjellmer I, Lagercrantz H, Thiringer K, et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Acta Paediatr 1993;82:925-9
14. Saugstad O. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988;23:143-50
15. Azzopardi D, Wyatt JS, Cady EB, Delpy DT, Baudin J, Stewart AL, et al. Prognosis of newborn infants with hypoxic ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 1989;25:445-51
16. Papile L, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500g. J Pediatr 1978;92:529-34
17. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 1979;25:131-8
18. Keller R, Oke A, Mefford I, Adams RN. Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. Life Sci 1976;19:995-1004
19. Simmonds RJ, Harkness RA. High-performance liquid chromatographic methods for base and nucleoside analysis in extracellular fluids and cells. J Chromatogr 1981;226:369-81
20. Sarnat HB. Impairment of late neuroblast migrations by ischemia. In: Lou H, Greisen G, Falck Larsen J, editors. Brain lesions in the newborn. Copenhagen: Munksgaard, 1994: 105-19
21. Rowland L, Fink M, Rubin L. Cerebrospinal fluid: blood-brain barrier, brain edema, and hydrocephalus. In: Kandel E, Schwartz J, Jessel TM, editors. Principles of neural science. 3rd ed., New York: Elsevier, 1991:1050-60
22. Takashima S, Becker L. Developmental changes of glial fibrillary acidic protein in cerebral white matter. Arch Neurol 1983;40:14-8
23. Roessmann U, Gambetti P. Pathological reactions of astrocytes in perinatal brain injury. Acta Neuropathol 1986;70:302-7
24. Ruth V, Autti RI, GranstrÖm ML, Korkman M, Raivio KO. Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values. J Pediatr 1988;113:880-5
25. Kothari JM, Sheftel D, Puppala B, Okrent D, Angst D. Serum neuron specific enolase in preterm infants at risk of intraventricular hemorrhage (IVH). Pediatr Res 1995; 218A